Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Artios Pharma synthesizes DNA polymerase inhibitors

Feb. 24, 2020

Sumitomo Dainippon Pharma discovers MEN1/KMT2A interaction inhibitors

Feb. 24, 2020

GlaxoSmithKline presents new ATF-4 inhibitors

Feb. 24, 2020

Incyte patents new hSTING receptor agonists

Feb. 24, 2020

FDA grants IND approval for Veyonda plus doxorubicin in soft tissue sarcomas

Feb. 24, 2020

Novel genetically engineered murine model of SCBC

Feb. 24, 2020

Revlimid capsules granted additional approval in Japan

Feb. 24, 2020

Oncofid-P-b shows promise in bladder cancer patients unresponsive to BCG

Feb. 21, 2020

Artios Pharma patents DNA polymerase eta inhibitors

Feb. 21, 2020

Sumitomo Dainippon Pharma describes anticancer chromen derivatives

Feb. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...